Skip to content
Catalyst

fucoxanthinFinding

Fucoxanthin inhibits TLR4

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“The expression of TLR4 and its downstream proteins myeloid differentiation factor 88 (MyD88), p-IκBα, and p-NF-κBp65 was significantly upregulated in the FFA group, and was significantly inhibited by treatment with fucoxanthin.”
Quoted verbatim from Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway.
This finding among the 2 findings on its endpoint

fucoxanthin

TLR4

inhibits

Who
Human Chang liver cell line, FFA-induced NAFLD cell model, fucoxanthin group
Dose studied
not reported

Very limited evidencePMID 35447899 · 2022

02 · The study

Study
in vitro · not in humans
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3PA4XQDZ34Q7XY1CZCPJA97